Concanavalin A dimers as therapeutic agents

Details Concanavalin A dimers as therapeutic agents Concanavalin A dimers as therapeutic agents

1987-03-03

1989-12-26

Rosen, Sam

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

435 1, 514 2, A61K 3710, A01N 102

Patent

active

048898422

ABSTRACT:
Homogeneous dimeric forms of concanavalin A, including the dimer form of native concanavalin A and dimeric derivatives of concanavalin A, are effective immunoregulatory agents with a good balance of high activity and low toxicity. Immunoregulatory pharmaceutical materials composed of one or a mixture of such isolated dimeric materials are disclosed as are methods of inducing immunoregulation in mammals by administering to such mammals an effective immunoregulatory amount of such pharmaceutical materials.

REFERENCES:
Gunther et al., (1973) Proc. Natl. Acad. Sci. USA, USA 70(4):1012-1016.
Edelman et al., (1973) Proc. Natl. Acad. Sci. USA 70:1442.
Kind et al., (1973) Proc. of the Soc. for Experimental Biology and Medicine 142:680.
Reichert et al., (1973) Nature New Biology 242:146.
Cunningham, (1975) Annals of the New York Acad. of Sci. 234:219.
Wang et al., (1975) Proc. Natl. Acad. Sci. USA 72:1917.
Wang et al., "Concanavalin A as a Tool," edited by H. Bittiger (Wiley Interscience publication, 1976).
Hadden et al., (1976) Proc. Natl. Acad. Sci. USA 73:1717.
Ozato et al., (1976) Journal of Experimental Medicine 143:1.
Bornens et al., (1976) J. Biochem. 65:61.
McClain et al, (1976) Journal of Experimental Medicine 144:1494.
Ozato et al., (1977) Journal of Cellular Physiology 93:153.
Basham et al., (1977) Journal of Immunology 118:863.
Rubens et al., (1977) Journal of Immunology 118:180.
Wang et al., (1978) Journal of Biological Chemistry 253:3000-3007.
Beppu et al., (1979) J. Biochem. 85:1275.
Kataoka et al., (1979) Gann 70:155.
Dobson et al., (1980) Biochem. Biophys. Acta 629:305.
Larner et al., (1980) Molecular & Cellular Biochemistry 32:123.
Blackard et al., (1980) Metabolism 29:691.
Ruud et al., (1981) Scand. J. Immunol. 14:153.
Koppel et al., (1982) Journal of Cell Biology 93:950.
Takahashi et al., (1982) Hepatology 2:249.
Zenian et al., (1982) J. Parisitol. 68:408.
Leak et al., (1984) Journal of Ultrastructure Research 86:1.
Romeo et al., (1978) Membrane Biol. 44:221
Smolen et al., (1980) Infection and Immunity 28:475.
Petty et al., (1981) Cell Biophys. 3:19.
Sheterline et al., (1981) Journal of Cell Biology 90:743.
Siraganian et al., (1975) J. of Immunology 114:886.
Santoro et al., (1983) Biochim. Biophys. Acta. 757:101.
Inoue et al., (1977) Biochim. Biophys. Acta 467:130.
Wise et al., (1978) J. Cell. Sci. 30:63.
Chicken et al., (1983) Biochem. Biophys. Acta 729:200.
Mehta et al., (1983) Biochim. Biophys. Acta. 762:9.
Garrity et al., (1982) Antimicrobial Agents and Chemotherapy 21:450.
Diaz-Maurino et al.-Chem. Abst. vol. 101, (1984) p. 21191g.

Affiliated with

Also associated with

Rating

Concanavalin A dimers as therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Concanavalin A dimers as therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Concanavalin A dimers as therapeutic agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1577310